ProductProductWhat are Generics?
Hyzaar
view photo
Generic Hyzaar Losartan - Hydrochlorothiazide 50mg + 12.5mg

Generic Hyzaar is used for treating high blood pressure. It may be used to decrease the risk of stroke in certain patients with high blood pressure.


Hypertension


PackagePricePer pillSavingsOrder
50mg + 12.5mg × 30 pills$48.20$ 1.61 
50mg + 12.5mg × 60 pills$92.40$ 1.54  $4.00
50mg + 12.5mg × 90 pills$117.60$ 1.31  $27.00
50mg + 12.5mg × 120 pills$142.80$ 1.19  $50.00
50mg + 12.5mg × 180 pills$193.20$ 1.07  $96.00
PRODUCT DESCRIPTION Show Product Info
Search for pillsSearch for pills

TestimonialsTestimonials
Well, I must apologize - I thought surely you were scamming me. But, all of a sudden, my mailbox overflows. I received one order on Thursday, 8 June, and then another on Saturday, 10 June. Almost 1 month from our first effort, but the postal service must be the culprits. With this double supply, you are now going to have to send me a couple of women, so the meds don't go to waste. How can we make this right? What would you like me to do? Thanks. I hope only good karma comes to you. - Curt
Read more »Read more »
NewsNews
    A pill for every problem - Montreal Gazette
    A pill for every problemMontreal GazetteThe yellow oval-shaped pill, Hyzaar, is taken to lower her high blood pressure, along with a white pill, Atenelol
    1 Unexcitingly Good Dividend Play - DailyFinance
    1 Unexcitingly Good Dividend PlayDailyFinanceRight now it's Merck's heart drugs Cozaar and Hyzaar, which plummeted 21% in the first quarter
    Merck: Will Singulair Expiration Sink Its Stock? - Citybizlist (press release)
    Merck: Will Singulair Expiration Sink Its Stock?Citybizlist (press release)The growth in pharmaceuticals was impacted by large drops in revenues from Remicade, Cozaar and Hyzaar
    Strong profit growth and Zetia patent win for Merck & Co - Pharma Times
    Strong profit growth and Zetia patent win for Merck & CoPharma TimesRevenues from the antihypertensives Cozaar (losartan) and Hyzaar (losartan plus hydrochlorothiazide) fell 21% to $336 million, due to generic competition
    Top global pharma cos post sales growth of just 3.4%, but net profit up by ... - pharmabiz.com
    Top global pharma cos post sales growth of just 3
Live support Online Chat


Our billing is certified by
Secure shopping certificates